T Cell Responses to Repeated SARS-CoV-2 Vaccination and Breakthrough Infections in Patients on TNF Inhibitor Treatment: A Prospective Cohort Study
Asia-Sophia Wolf,Kristin H. Bjorlykke,Hilde S. Orbo, Sabin Bhandari,Guri Solum,Ingrid Fadum Kjonstad,Ingrid Jyssum,Unni C. Nygaard,Anja Brathen Kristoffersen,Ingrid E. Christensen, Sarah E. Josefsson,Katrine Persgard Lund,Adity Chopra,Julie Rokke Osen,Viktoriia Chaban,Anne T. Tveter,Joseph Sexton, Tore K. Kvien,Jorgen Jahnsen,Espen A. Haavardsholm,Gunnveig Grodeland,John Torgils Vaage,Sella A. Provan,Hassen Kared,Fridtjof Lund-Johansen,Ludvig A. Munthe,Silje Watterdal Syversen,Guro Lovik Goll,Kristin Kaasen Jorgensen,Siri Mjaaland EBioMedicine（2024）
Key words
TNF inhibitors,SARS-CoV-2,Vaccination,T cells,Inflammatory bowel disease,Arthritis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper